Taiwanese Pharmaceuticals & Biotech High And Sustainable

Results

0 new

Companies in a sound financial shape with a dividend yield of more than 5%.

3 companies

TSH Biopharm

Market Cap: NT$2.0b

Develops and markets pharmaceutical products in Taiwan.

8432

NT$51.00

4.5%

6.4%

Allied Biotech

Market Cap: NT$2.2b

Engages in the manufacture and sale of carotenoids worldwide.

1780

NT$23.35

-1.9%

31.9%

TTY Biopharm

Market Cap: NT$18.9b

Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan, the United States, and internationally.

4105

NT$76.10

0.9%

0.7%